Is Bone Biologics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Bone Biologics Corp (BBLG) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bone Biologics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bone Biologics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Bone Biologics Corp?

Muslim investors may consider investing in Bone Biologics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bone Biologics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Bone Biologics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bone Biologics Corp updated?

The Shariah compliance status of Bone Biologics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bone Biologics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bone Biologics Corp?

You can check the latest Shariah compliance status of Bone Biologics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BBLG Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 04, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Bone Biologics Corp (BBLG)

Based on 7 analysts giving stock ratings to Bone Biologics Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Bone Biologics Corp. Stock Analysis BBLG

United States Health Care Nano Cap Report: 2025 Annual

Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Key Statistics of Bone Biologics Corp (BBLG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.27$1.29

Today's Open

$1.27

Volume

12.35K

P/E Ratio (TTM)

52 Week Range

$1.05$6.75

Market Cap

2.37M

Avg. Volume

9607.74

Dividend Yield

Financial Metrics & Statements of Bone Biologics Corp (BBLG)

FAQ's for Bone Biologics Corp (BBLG)

According to Musaffa’s Shariah screening methodology, Bone Biologics Corp (BBLG) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.